IRB meeting dates and submission deadlines

MCP IRB committee meets every 2nd Wednesday of each month from 12:00 PM to 1:00 PM. Per regulations, IRB members must be provided with research materials sufficiently in advance to allow review of the material to prepare for any deliberation and voting. Per local policy, this is generally one week before the meeting. Therefore, the submission deadline is ten (10) business days before each IRB meeting to allow for any changes and to meet the review timeline. Submit materials following the IRB submission checklist and instructions on each applicable form.

Below is a schedule of IRB meetings and submission deadlines for Initial, continuing and amendment (modification) applications that involve greater than minimal risk to subjects. Submit all documents via irbnet.org. For all IRB submissions, an original signature is not required. The Principal Investigator must sign all packages before they are submitted for IRB review.

IRB Meeting DateSubmission Deadline
January 13, 2021 December 30, 2020
February 10, 2021 January 27, 2021
March 10, 2021 February 24, 2021
April 14, 2021 March 31, 2021
May  12, 2021 April 28, 2021
June 09, 2021 May 26, 2021
July 14, 2021 June 30, 2021
August 11, 2021 July 28, 2021
September 08, 2021 August 25, 2019
October 13, 2021 September 29, 2021
November 10, 2021 October 27, 2021
December 08, 2021 November 24, 2021
January 12, 2022 December 29, 2021
February 09, 2022 January 26, 2022
March 09, 2022 February 23, 2022
April 13, 2022 March 30, 2022
May 11, 2022 April 27, 2022
June 08, 2022 May 25, 2022
July 13, 2022 June 29, 2022
August 10, 2022 July 27, 2022
September 14, 2022 August 31, 2022
October 12, 2022 September 28, 2022
November 09, 2022 October 26, 2022
December 14, 2022 November 30, 2022
January 11, 2023 December 28, 2022

*Note: Submissions received on the deadline date must be complete and review ready to be placed on the Agenda for review at next convened board meeting.

Training and education

MCP IRB will accept evidence of completion for Human Subject Protection training or any Good Clinical Practice training that is mutually acceptable by TransCelerate BioPharma, Inc. member companies. Examples of acceptable training include, but are not limited to:   

  • PHRP Online - Protecting Human Research Participants (PHRP) eLearning Course. This course is available for a cost of $39.99.
  • CITI Program - The Collaborative Institutional Training Initiative (CITI) Human Subject Research or additional applicable course offerings. There is a cost associated with each course. However, if you are affiliated with an organization, that has a membership with CITI Program; training may be available to you at no cost.
  • ACRP Program – Association of Clinical Research Professionals (ACRP) “Ethics and Human Subject Protection” is available at no cost to you. To access the course, you would need to register and choose “Pricing Without Contact Hours”. Follow the prompts to complete the course.
  • OHRP – Human Research Protection Training – Office of Human Research Protections (OHRP) offers comprehensive training based on the revised Common Rule. This training takes approximately 4.5 hours to complete.
  • Medical City Health employees may complete the course “Introduction to Good Clinical Practice” in HealthStream [accessible only from an internal computer]. This training takes about 2 hours to complete.
  • MCP IRB will consider other forms of education in protection of human subjects on a case-by-case basis.

Average completion time for each course is different. You do not have to complete an entire course in one sitting. You can log in and out of a course to complete it at your convenience.

Certificates evidencing completion of training must be submitted via IRBNet for IRB review. If training was completed at another institution, please submit a copy of the training certificate to determine if it meets MCP IRB training requirements.

Unless otherwise specified, training must be renewed every three (3) years as long as the study team member is involved in an active study under IRB oversight.